NEW FRONTIER HEALTH CORP - ORD SHS (NFH)

CUSIP: G6461G106

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / ORD SHS
Total 13F shares
58,093,736
Share change
+22,400,790
Total reported value
$479,274,000
Price per share
$8.25
Number of holders
23
Value change
+$180,751,713
Number of buys
14
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP G6461G106?
CUSIP G6461G106 identifies NFH - NEW FRONTIER HEALTH CORP - ORD SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEW FRONTIER HEALTH CORP - ORD SHS (NFH) as of Q1 2020

As of 31 Mar 2020, NEW FRONTIER HEALTH CORP - ORD SHS (NFH) was held by 23 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 58,093,736 shares. The largest 10 holders included Vivo Capital, LLC, Capital Research Global Investors, Fosun International Ltd, Aspex Management (HK) Ltd, MORGAN STANLEY, York Capital Management Global Advisors, LLC, BAMCO INC /NY/, Capital International Investors, UBS OCONNOR LLC, and BosValen Asset Management Ltd. This page lists 23 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.